Monash IVF Group Limited

ASX MVF.AX

Monash IVF Group Limited Net Income for the year ending June 30, 2024: USD -4.35 M

Monash IVF Group Limited Net Income is USD -4.35 M for the year ending June 30, 2024, a -129.94% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Monash IVF Group Limited Net Income for the year ending June 30, 2023 was USD 14.53 M, a 14.42% change year over year.
Monash IVF Group Limited Net Income for the year ending June 30, 2022 was USD 12.70 M, a -32.63% change year over year.
Monash IVF Group Limited Net Income for the year ending June 30, 2021 was USD 18.86 M, a 132.95% change year over year.
Monash IVF Group Limited Net Income for the year ending June 30, 2020 was USD 8.09 M, a -41.93% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

ASX: MVF.AX

Monash IVF Group Limited

CEO	Mr. Michael D. Knaap
IPO Date	June 26, 2014
Location	Australia
Headquarters	Pelaco Building 1
Employees	997
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Dental Care Medical Instruments Professional Services Telehealth Venture Capital

Description

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.

Key trends

Past 5 years